key: cord-0317828-4m78n8ot
authors: Zuercher, K.; Mugglin, C.; Egger, M.; Mueller, S.; Fluri, M.; Bolick, L.; Piso, R. J.; Hoffmann, M.; Fenner, L.
title: Vaccination willingness for COVID-19 among health care workers in Switzerland
date: 2021-07-06
journal: nan
DOI: 10.1101/2021.07.04.21255203
sha: b83b845b01e649ac0e3563f97cb8df66935f08db
doc_id: 317828
cord_uid: 4m78n8ot

Aims of the study: Vaccination is regarded as the most promising response to the COVID-19 pandemic. We assessed opinions towards COVID-19 vaccination, willingness to be vaccinated, and reasons for vaccination hesitancy among health care workers (HCWs). Methods: We conducted a cross-sectional, web-based survey among 3,793 HCWs in December 2020 in the Canton of Solothurn, Switzerland, before the start of the national COVID-19 vaccination campaign. Results: Median age was 43 years (interquartile range [IQR] 31-53), 2,841 were female (74.9%). 1,511 HCWs (39.8%) reported willingness to accept vaccination, while 1,114 (29.4%) were unsure, and 1,168 (30.8%) would decline vaccination. Among medical doctors, 76.1% were willing, while only 27.8% of nurses expressed willingness. Among 1,168 HCWs who would decline vaccination, 1,073 (91.9%) expressed concerns about vaccine safety and side effects. The willingness of HCWs to be vaccinated was associated with older age (adjusted odds ratio [aOR] 1.97, 95%Cl 1.71-2.27) and having been vaccinated for influenza this year (aOR 2.70, 95%Cl 2.20-3.31). HCWs who reported a lack of confidence in government were less likely to be willing to be vaccinated (aOR 0.58, 95%Cl 0.40-0.84), and women were less willing to be vaccinated than men (OR 0.33 (0.28-0.38). Conclusion: Less than half of HCWs reported willingness to be vaccinated before the campaign start, but proportions varied greatly depending on the profession and workplace. Strategies with clear and objective messages that particularly address the concerns of HCWs are needed if their willingness to be vaccinated is to be increased.

The worldwide spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and coronavirus disease 2019 (COVID-19) is a major public health threat (1) . Globally, SARS-CoV-2 infection has been confirmed in over 131,837,512 people and as of 7 April, 2021 2,862,664 have died from COVID-19 (2) . In Switzerland, 612,575 COVID-19 cases have been confirmed and more than 9,772people have died from COVID-19 (3) .

The pandemic has stretched the health care system in Switzerland to its limits and burdened the economy with temporary closures of restaurants and stores and large public and private venues (4) . In the absence of effective treatments and a safe and effective vaccine, nonpharmaceutical interventions (NPIs) were implemented to mitigate the pandemic. Measures taken include using personal protective equipment (PPE) such as face masks in public spaces, keeping distance between individuals, and rigorous hand hygiene. Many pharmaceutical companies and research laboratories have been working on vaccines (5) (6) (7) . Effective vaccination is key to controlling the COVID-19 pandemic, but global vaccine distribution is challenging (8) .

By the end of 2020, several vaccines had demonstrated efficacy in phase 3 trials (7), and by the beginning of January 2021, two vaccines had been approved by the Swiss Agency for Therapeutic Products (Swissmedic) (9, 10) .

The delivery of the COVID-19 vaccines started on 4 January 2021, making it essential to identify and address widespread vaccine uptake barriers. Scepticism about these new vaccines against COVID-19 presents one such challenge to vaccine uptake. Health care workers (HCWs), who face an increased risk of infection with SARS-CoV-2 and can transmit the virus among themselves and to highly . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.04.21255203 doi: medRxiv preprint vulnerable patients (11) (12) (13) (14) (15) are an important target group for vaccination. Previous studies have shown that vaccine uptake for vaccine-preventable diseases such as influenza is low among HCWs (16, 17). Given the central role they play in treating COVID-19 and administering vaccinations, HCWs are uniquely positioned to influence vaccine uptake. Therefore, understanding the willingness of HCWs to be vaccinated against COVID-19, mainly if they are themselves hesitant, will be important in promoting vaccine uptake in the population.

We, therefore, assessed the willingness of healthcare workers in the Canton of Solothurn, Switzerland, to be vaccinated against influenza and COVID-19, and inquired about reasons for vaccine hesitancy among them.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.04.21255203 doi: medRxiv preprint

We conducted a cross-sectional web-based survey among HCWs in the Canton of Solothurn, Switzerland. We included adults aged 16 or older who work in the health care system in hospitals, medical practices, retirement and nursing homes, home care, pharmacies, and long-term care facilities.

We developed and pilot tested a standardised questionnaire based on the study of questionnaire collected information of three types: (i) demographic details such as sex, age, and profession; (ii) intention to be vaccinated against COVID-19 and reasons for being vaccinated/not being vaccinated or for being unsure, confidence in government, recommendation of the employer, and additional information needed to take a vaccination decision; (iii) history of influenza vaccination for influenza season 2020/21. We collected the data in mid-December 2020 before the first approval of a COVID-19 vaccine and associated campaigning using a web-based tool (www.findmind.ch).

All employees of the cantonal hospital in the Canton of Solothurn were invited to participate. The survey was also sent to the cantonal professional associations of physicians, nursing homes, long-term care facilities, and residential care, which invited their members to participate.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.04.21255203 doi: medRxiv preprint

The Swiss Federal Office of Public Health (FPOH) defined the following COVID-19 risk groups: persons over the age of 50; those with comorbidities including hypertension, chronic respiratory diseases, diabetes, being immunocompromised, cardiovascular disease, cancer, or obesity (BMI >30); persons who live in a nursing home or long-term care facility; and those who are pregnant.

The survey participants fell into three groups: persons willing to be vaccinated, those who were not willing to be vaccinated, and those who were hesitant or unsure about being vaccinated. Among those willing to be vaccinated against COVID-19, the reasons for deciding to do so could be characterised as self-protection, individual vaccination as a contribution to pandemic control, and membership in a risk group for severe COVID-19 disease. Reasons for unwillingness to be vaccinated included opposition to vaccines in general, the perception that COVID-19 is harmless or that PPE is sufficient, concerns about the effectiveness of the vaccine, its safety and side effects, bad experiences with previous vaccinations, fear of needles, and other reasons. People who were unsure about being vaccinated against COVID-19 were hesitant due to perceived inconsistent information, doubt about vaccine effectiveness, doubt about vaccine safety and fear of side effects, doubt about individual vaccination for pandemic control, and uncertainty among colleagues, and lack of information provided by the employer. Supplementary Table S1 provides further ore details.

We used descriptive statistics to characterise the study population by profession and intention to vaccinate against COVID-19. Differences between groups were assessed using chi-square, t-test, or Wilcoxon rank-sum tests as appropriate. We . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.04.21255203 doi: medRxiv preprint calculated the proportions of intention to be vaccinated against COVID-19 with the corresponding 95% confidence intervals (95% CI).

We examined factors associated with the HCW's intention to be vaccinated against COVID-19 in univariate and multivariate logistic regression. Logistic models were adjusted for age group and profession, confidence in government reports, the employer's recommendation, and influenza vaccine uptake 2020/21. We grouped uncertainty about vaccination and having no intention of being vaccinated against COVID-19. We also performed a sensitivity analysis that combined those who were willing to be vaccinated and those who were not sure about vaccination. Finally, we compared the vaccine refusers and those who were unsure about COVID-19 vaccination. All analyses were performed in Stata (version 15.1, College Station, TX, USA).

Data collection was anonymous. No ethical approval was needed, in line with the Swiss Human Research Act.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.04.21255203 doi: medRxiv preprint

A total of 4,244 HCWs participated in the survey. Response rates were as follows: ~64% (2,679/~4,200) among hospital staff, ~38% (338/~900) among medical practice staff, ~11% (440/~4,000) among nursing home staff, and ~29%

(470/~1,600) among long term care facility staff.

We excluded participants who did not fully complete the survey (n=421) and those for whom data on sex, age, or profession were missing (n=12). We further excluded participants younger than 16 years (n=18). The analyses thus included 3,793 HCWs ( Figure S1 ).

The median age of HCW participants was 43 years (interquartile range [IQR] 31-53), 2,841 were female (74.9%). Among all HCWs, 2,445 (64.5%) worked in hospitals, 398 (10.5%) worked in long-term care facilities, 373 (9.8%) in retirement and nursing homes, 311 (8.2%) in medical practices, 232 (6.1%) in residential care, and 34 (0.9%) at pharmacies (Table 1 and Table S2 ). Asked about COVID-19 vaccination, 1,511 HCWs (39.8%) reported they planned to take the COVID-19 vaccine, 1,114 (29.4%) said they were unsure, and 1,168 (30.8%) said they would not take the vaccination. Willingness to vaccinate was highest among medical doctors, among whom467 of 617 (76.1%) were willing to be vaccinated, and it was lowest among is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.04.21255203 doi: medRxiv preprint vaccination rate was highest among medical doctors (75.6%) and pharmacists (58.8%). Among the other professions, the vaccination rate ranged from 11.6% to 44.4% (Table 1) .

The willingness among HCWs to be vaccinated against COVID-19 was lower among females than male participants (OR 0.33, 95%Cl 0.28-0.38) and increased with age.

Willingness was highest among the age group ≥ 60 years (OR 4.56, 95%Cl 3.50-5.94) compared to the age group <30 years. HCWs reporting having been vaccinated against seasonal influenza 2020/21 were more willing to be vaccinated against COVID-19 (OR 6.30, 95%Cl 5.45-7.23) compared to the unvaccinated group.

Confidence in government reports and employers' vaccination recommendation were associated with willingness to be immunised against COVID-19: OR 4.12 (95%Cl 3.37-5.03) and OR 14.19 (95%Cl 11.53-17.47), respectively. In contrast, lack of such confidence was negatively associated with willingness to get vaccinated compared to the group with no opinion ( Table 2 ). The willingness to be vaccinated against COVID-19 was higher among pharmacists (OR 6.22, 95%Cl 2.96-13.13) and medical doctors (OR 8.24, 95%Cl 6.66-12.21) compared to nurses.

In the multivariate analysis, willingness to be vaccinated was positively associated with confidence in government reports on the COVID-19 pandemic (aOR 1.59 95%Cl 1.23-2.06) and negatively with lack of confidence in government (aOR 12.85 95%Cl 10.11-16.33). Similarly, confidence in employer recommendations was positively associated, whereas lack of confidence was negatively associated. The analysis confirmed that HCWs who reported vaccination against seasonal influenza 2020/21 were more likely to be willing to be vaccinated against COVID-19 than those who were not vaccinated (aOR 2.70 95%Cl 2.20-3.31) ( Table 2 ). . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.04.21255203 doi: medRxiv preprint

In the sensitivity analysis grouping the willing and unsure together (rather than the refusers and unsure), results were similar to the primary analysis (Table S3) .

The main reasons for willingness to be vaccinated were personal protection, controlling the pandemic, and belonging to a risk group ( Figure 2A , Table 1 ). These reasons were different by profession (p<0.05). The most frequent reasons for vaccine hesitancy among HCWs included concerns about vaccine safety and side effects (1073/1,168, 91.9%), the perception that personal protective equipment is sufficient (328/1,168, 28.1%), and that COVID-19 is harmless (231/1,168, 19.8% Figure 2B and Table 1 ). All reasons for vaccine hesitancy were similar in the different HCW professions, except for vaccine safety and side effects, which was mentioned more frequently as a reason for vaccine hesitancy among nurses (p=0.01) Among 1,114 HCWs who were unsure about a vaccination decision, 1,055 (94.7%) wanted more information on vaccine safety and side effects, 778 (69.6%) awaited reports from already vaccinated people, and 404 (36.3%) wanted an opinion from experts. The main reasons can be found in Figure 2C , Table 1 . The reasons for being unsure were similar across the HCW professions, but pharmacists wanted more frequently information on the vaccine than medical doctors (100% vs. 88%, p=0.01).

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 6, 2021.

Less than half of participating HCWs reported willingness to be vaccinated against COVID-19. The most frequently given reason for vaccine hesitancy was concern about vaccine safety and side effects. Nurses were less likely to be willing to be vaccinated against COVID-19 than were medical doctors and pharmacists.

Vaccines are an effective control measure to reduce the burden of infectious disease. Poliomyelitis was eradicated, and we are close to eliminating measles, mumps, and rubella with vaccines (19). Vaccination will play an important role in the control of the COVID-19 pandemic. Even transient herd immunity in Switzerland will require an estimated 60% of the population to achieve immunity to SARS-CoV-2 either through infection and recovery or vaccination, not considering the potential impacts of SARS-CoV-2 variants of concern. This proportion varies depending on model assumptions (20).

Willingness to get vaccinated is central to achieving herd immunity. Several cross-sectional studies have assessed the willingness to get vaccinated. In seven countries, a European general population survey found that the willingness to be vaccinated against SARS-CoV-2 ranged from 62% to 80% (21). Similar results were found in the United Kingdom and Ireland, with 69% and 65% acceptance, respectively (22). In the USA, 37% of HCWs reported to be willing to get vaccinated against COVID-19 (23). These results are in line with our results (40%) in the Canton of Solothurn in Switzerland. These numbers cause concern because HCWs play an important role in vaccine uptake among the general population. A review on vaccine hesitancy has shown that vaccinated HCWs are more likely to recommend vaccination than unvaccinated HCWs (24). Furthermore, a vaccination . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 6, 2021. ; recommendation given by an HCW is frequently cited as the reason for vaccination acceptance (25). In contrast, the lack of such a recommendation was the most common reason for not being vaccinated (24, 26). Researchers have been developing mRNA and viral vector-based vaccines for other diseases for more than a decade (28). As the pandemic spread, public willingness and even demand led to rapid enrolment in phase I through to phase III clinical trials with historically unprecedented speed. Simultaneously, the rapid spread of SARS-CoV-2 allowed endpoint-driven phase III trials to demonstrate vaccine efficacy sooner than was expected at their outset.

We found that confidence in the governmental authorities is associated with willingness to get vaccinated against COVID-19. During a health crisis or a pandemic, trust in the government and risk perception play a key role in vaccine acceptance (29, 30). A French survey among general practitioners showed they were more likely to recommend vaccines to patients when they trusted official sources of information (31). A global survey also reported an association between vaccine acceptance and participants' trust in government (32). High levels of trust in government was associated with willingness to follow governmental recommendations on preventive behaviors to contain swine flu (33) or compliance . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 6, 2021. ;  with social distancing measures during the Ebola outbreak (34). In contrast, mistrust and misinformation reduced compliance with social and behavioural measures (35).

A cross-sectional study during the COVID-19 pandemic among UK residents showed that residents who trusted the government to control the pandemic were more likely to follow government recommendations during the lockdown (36).

Strategies to increase vaccine coverage among HCWs should draw upon guidance from authorities or persons conceived as such by a target audience (in this case HCWs) and specific information about vaccine safety and efficacy. Thus, it is not surprising that many undecided HCWs want to have reports from fellow HCWs who have been vaccinated before they make up their minds. Peers provide important information that influences decision-making, but this source of information is often overlooked. HCWs may be the most effective promotors of vaccination for their fellow workers.

We observed that HCWs who were vaccinated against seasonal influenza are also more likely to willing to be vaccinated against COVID-19. Both diseases are contagious respiratory diseases caused by viruses, and they share some of the same symptoms (fever, cough) and approaches for prevention (hand hygiene, physical distancing, and masks). However, there are important differences.

Superspreader events are more common for COVID-19 (37), and mortality rates are higher for COVID-19 than for influenza (38, 39). A recent study showed that over time, the uptake of the seasonal influenza vaccine in Switzerland had dropped overall and among older persons (≥65 years) and people with chronic disease (40).

This reduced coverage might be explained by variable and lower seasonal influenza vaccine effectiveness, which can range from 30-60% (41, 42).

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 6, 2021. ;

The limitations of this study include different response rates among the HCW professions and potential over-representation of hospital-based HCWs. We conducted a web-based cross-sectional online survey in which participation was 

We would like to thank all HCWs who were willing to participate. Further, we would like to thank all the institutions for distributing the survey to their employees. We thank Christopher Ritter for editorial assistance.

There was no specific funding for this project. KZ was supported by grant U01AI069924 from the U.S. National Institutes of Health's National Institute of Allergy and Infectious Diseases. ME was supported by special project funding (grant 189498) from the Swiss National Science Foundation.

All authors declare that they have no conflicts of interest.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 6, 2021. ;

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 6, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 6, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 6, 2021. ; .

It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 6, 2021. .

It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 6, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 6, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 6, 2021. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 6, 2021. ; Figure 2 : Reasons for vaccine willingness (A), vaccine hesitance (B) and being uncertain (C) to Covid-19 among all HCWs. The exact numbers can be found in Table 1. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 6, 2021. Vaccine for pandemic control Because this is the only way to stop the pandemic. Because I belong to the risk groups.

Risk group Reasons for hesitancy to be vaccinated I think vaccinations are generally unnecessary.

Opponents of vaccination Vaccination against COVID-19 is not necessary.

COVID-19 is harmless I don't think COVID-19 is dangerous for my health. COVID-19 is no worse than the flu. I don't think the vaccine is effective.

Effectiveness of the vaccine I think the COVID-19 vaccine may not be safe. I am concerned that the vaccine was approved too quickly and has not been tested enough Vaccine safety and side effects I am afraid of possible side effects. I have had a bad experience or reaction to a previous vaccination Bad experiences with vaccines I had a bad experience with vaccinations at a previous physician or health clinic. I am afraid of needles.

Fear of needles I am already protected because I comply with protective measures (masks, hand hygiene).

Personal protective equipment is sufficient I protect my environment because I follow the protective measures, therefore vaccination is unnecessary. Because some colleagues do not want to be vaccinated either.

Other Because the experts' opinions are inconsistent The best way is to let nature take its course. Religious reasons.

The information is inconsistent Inconsistent information The vaccines were too fast/quickly approved Swissmedic Vaccine safety and side effects I fear possible side effects. I don't know if the vaccination will provide protection for me and/or others.

Effectiveness of the vaccine I don't know if my vaccination will help contain the pandemic (herd immunity).

Vaccine for pandemic control My colleagues are also unsure or against vaccination.

Uncertainty of my colleagues I have not yet been educated by my employer.

Education by employer Other Information needed to take a decision General information about the disease COVID-19.

Information about COVID-19 Information on the safety of the vaccination.

Information's about vaccine (safety, effectiveness, side effects) Information about possible side effects of the vaccination. Information about the effectiveness of the vaccination (does it protect me?) Information about the vaccination procedure (e.g. how often vaccination is necessary). Experiences and reports from people who have already been vaccinated.

Reported experiences from vaccinated people A statement from experts Opinion by experts . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 6, 2021. ; 1 Other medical staff includes physical therapists, occupational therapists, speech therapists, and midwives . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 6, 2021. ; .

It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 6, 2021. Figure S1 : Flow chart.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 6, 2021. ;

A Novel Coronavirus from Patients with Pneumonia in China

World Health Organization. Coronavirus Disease (COVID-19) Dashboard Geneva: World Health Organization

Coronavirus: Situation Schweiz Bern Federal Office of Public Health

The socio-economic implications of the coronavirus pandemic (COVID-19): A review

Looking beyond COVID-19 vaccine phase 3 trials

Keeping track of the SARS-CoV-2 vaccine pipeline

COVID-19 vaccine tracker London: London School of Hygiene & Tropical Medicine

Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis

Swissmedic grants authorisation for the first COVID-19 vaccine in Switzerland Bern: Swissmedic

Swissmedic grants authorisation for the COVID-19 vaccine from Moderna: Second COVID-19 vaccine authorised in Switzerland Bern: Swissmedic

COVID-19 and Italy: what next? The Lancet. 2020. 12. International Council of Nurses. International Council of Nurses High proportion of healthcare workers with COVID-19 in Italy is a stark warning to the world: protecting nurses and their colleagues must be the number one priority

Geneva: International Council of Nurses

Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital

SARS-CoV-2 infection in Health Care Workers

SARS-CoV-2 setting-specific transmission rates: a systematic review and meta